
Results
270
Most Popular Stocks on the market
270 companies
Samsung BiologicsLtd
Market Cap: ₩69.0t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,491,000.00
7D
0.8%
1Y
-5.9%
Celltrion
Market Cap: ₩43.6t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩190,300.00
7D
5.7%
1Y
11.9%
ALTEOGEN
Market Cap: ₩19.3t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩277,000.00
7D
27.5%
1Y
-18.1%
Samsung Epis Holdings
Market Cap: ₩9.7t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩389,000.00
7D
10.4%
1Y
n/a
SK Biopharmaceuticals
Market Cap: ₩6.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩82,000.00
7D
8.5%
1Y
-19.2%
Yuhan
Market Cap: ₩5.6t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩75,100.00
7D
6.8%
1Y
-34.4%
Hanmi Pharm
Market Cap: ₩4.8t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩380,000.00
7D
18.0%
1Y
34.0%
ABL Bio
Market Cap: ₩4.5t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩80,200.00
7D
26.7%
1Y
4.7%
LigaChem Biosciences
Market Cap: ₩4.0t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩109,500.00
7D
32.1%
1Y
-26.8%
Peptron
Market Cap: ₩4.0t
Engages in the development of peptide-based medicines.
A087010
₩171,500.00
7D
26.8%
1Y
-45.2%
PharmaResearch
Market Cap: ₩3.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩378,000.00
7D
-3.3%
1Y
-36.8%
Sam Chun Dang Pharm
Market Cap: ₩3.9t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩166,600.00
7D
31.7%
1Y
-12.7%
Caregen
Market Cap: ₩3.1t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩63,600.00
7D
26.9%
1Y
30.5%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩260,000.00
7D
13.3%
1Y
-24.0%
SK bioscienceLtd
Market Cap: ₩2.7t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩34,600.00
7D
6.5%
1Y
-24.6%
Hanall Biopharma
Market Cap: ₩2.7t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩53,100.00
7D
27.3%
1Y
91.7%
Voronoi
Market Cap: ₩2.7t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩147,500.00
7D
38.0%
1Y
24.4%
OliX Pharmaceuticals
Market Cap: ₩2.6t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩121,500.00
7D
29.1%
1Y
135.9%
D&D Pharmatech
Market Cap: ₩2.4t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩53,100.00
7D
9.1%
1Y
55.1%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩100,800.00
7D
11.3%
1Y
10.9%
Celltrion Pharm
Market Cap: ₩1.9t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩42,000.00
7D
9.1%
1Y
-20.2%
Mezzion PharmaLtd
Market Cap: ₩1.7t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩56,900.00
7D
9.0%
1Y
49.9%
Kolon TissueGene
Market Cap: ₩1.6t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩18,660.00
7D
41.4%
1Y
-53.5%
Aimed Bio
Market Cap: ₩1.6t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩24,300.00
7D
34.0%
1Y
n/a
L&C BIOLTD
Market Cap: ₩1.6t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩57,800.00
7D
10.5%
1Y
78.1%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,500.00
7D
2.0%
1Y
-8.7%
NatureCellLtd
Market Cap: ₩1.4t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩22,150.00
7D
-2.4%
1Y
-10.5%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩122,300.00
7D
8.0%
1Y
-10.8%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩33,600.00
7D
15.3%
1Y
6.5%
Orum Therapeutics
Market Cap: ₩1.3t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩59,000.00
7D
49.2%
1Y
159.3%
Seegene
Market Cap: ₩1.3t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩28,050.00
7D
10.2%
1Y
-6.5%
JS Link
Market Cap: ₩1.2t
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩35,350.00
7D
18.0%
1Y
123.6%
HK inno.N
Market Cap: ₩1.1t
Engages in the pharmaceutical business in South Korea.
A195940
₩40,500.00
7D
12.5%
1Y
-11.1%
Rznomics
Market Cap: ₩891.8b
Develops RNA based gene therapies for cancers and intractable diseases.
A476830
₩32,000.00
7D
51.3%
1Y
n/a
Qurient
Market Cap: ₩890.6b
A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.
A115180
₩21,600.00
7D
42.7%
1Y
109.5%
Chong Kun Dang Pharmaceutical
Market Cap: ₩889.4b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩67,500.00
7D
2.9%
1Y
-18.2%